Cargando…
Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707972/ https://www.ncbi.nlm.nih.gov/pubmed/28714047 http://dx.doi.org/10.1007/s10875-017-0418-2 |
| _version_ | 1783445935328591872 |
|---|---|
| author | Wasserman, Richard L. Melamed, Isaac R. Stein, Mark R. Jolles, Stephen Norton, Miranda Moy, James N. |
| author_facet | Wasserman, Richard L. Melamed, Isaac R. Stein, Mark R. Jolles, Stephen Norton, Miranda Moy, James N. |
| author_sort | Wasserman, Richard L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6707972 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67079722019-09-06 Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency Wasserman, Richard L. Melamed, Isaac R. Stein, Mark R. Jolles, Stephen Norton, Miranda Moy, James N. J Clin Immunol Erratum Springer US 2017-07-17 2017 /pmc/articles/PMC6707972/ /pubmed/28714047 http://dx.doi.org/10.1007/s10875-017-0418-2 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Erratum Wasserman, Richard L. Melamed, Isaac R. Stein, Mark R. Jolles, Stephen Norton, Miranda Moy, James N. Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency |
| title | Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency |
| title_full | Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency |
| title_fullStr | Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency |
| title_full_unstemmed | Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency |
| title_short | Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency |
| title_sort | erratum to: evaluation of the safety, tolerability, and pharmacokinetics of gammaplex® 10% versus gammaplex® 5% in subjects with primary immunodeficiency |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707972/ https://www.ncbi.nlm.nih.gov/pubmed/28714047 http://dx.doi.org/10.1007/s10875-017-0418-2 |
| work_keys_str_mv | AT wassermanrichardl erratumtoevaluationofthesafetytolerabilityandpharmacokineticsofgammaplex10versusgammaplex5insubjectswithprimaryimmunodeficiency AT melamedisaacr erratumtoevaluationofthesafetytolerabilityandpharmacokineticsofgammaplex10versusgammaplex5insubjectswithprimaryimmunodeficiency AT steinmarkr erratumtoevaluationofthesafetytolerabilityandpharmacokineticsofgammaplex10versusgammaplex5insubjectswithprimaryimmunodeficiency AT jollesstephen erratumtoevaluationofthesafetytolerabilityandpharmacokineticsofgammaplex10versusgammaplex5insubjectswithprimaryimmunodeficiency AT nortonmiranda erratumtoevaluationofthesafetytolerabilityandpharmacokineticsofgammaplex10versusgammaplex5insubjectswithprimaryimmunodeficiency AT moyjamesn erratumtoevaluationofthesafetytolerabilityandpharmacokineticsofgammaplex10versusgammaplex5insubjectswithprimaryimmunodeficiency AT erratumtoevaluationofthesafetytolerabilityandpharmacokineticsofgammaplex10versusgammaplex5insubjectswithprimaryimmunodeficiency |